Human Genome Epidemiology Literature Finder
|
Records 1 - 30 (of 81 Records) |
| Query Trace: Disease and CEBPA[original query] |
|---|
| KAT6A amplifications are associated with shorter progression-free survival and overall survival in patients with endometrial serous carcinoma. PloS one 2020 9 15 (9): e0238477. Saglam Ozlen, Tang Zhenya, Tang Guilin, Medeiros L Jeffrey, Toruner Gokce |
| [Efficacy of Haploidentical Hematopoietic Stem Cell Transplantation in Treatment of Intermediate Risk Acute Myeloid Leukemia with Negative for FLT3-ITD, NPM1 or Biallelic CEBPA Mutation]. Zhongguo shi yan xue ye xue za zhi 2020 6 28 (3): 731-736. Chen Chun, Qi Jia-Qian, Chu Tian-Tian, Wang Hong, Wu De-Pei, Ruan Chang-Geng, Han Y |
| [Prognostic significance of minimal residual disease before post-remission therapy in younger adult acute myeloid leukemia patients with intermediate risk and negative of FLT3-ITD, NPM1 and biallelic CEBPA mutations]. Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi 2020 5 40 (7): 597-601. Zhang Y, Zhang Y M, Zhang Y S, Tang G S, Zhang W P, Yang J M, Wang J M, Hu X |
| Additional mutations in IDH1/2-mutated patients with acute myeloid leukemia. International journal of laboratory hematology 2021 7 43 (6): 1483-1490. Lu Jingtao, Chen Meiyu, Hua Haiying, Qin Wei, Zhang Ri, Lu Xuzhang, Chao Hongyi |
| What Is Abnormal in Normal Karyotype Acute Myeloid Leukemia in Children? Analysis of the Mutational Landscape and Prognosis of the TARGET-AML Cohort. Genes 2021 May 12 (6): . Herlin Morten Krogh, Yones Sara A, Kjeldsen Eigil, Holmfeldt Linda, Hasle Henr |
| Profiling of somatic mutations and fusion genes in acute myeloid leukemia patients with FLT3-ITD or FLT3-TKD mutation at diagnosis reveals distinct evolutionary patterns. Experimental hematology & oncology 2021 4 10 (1): 27. Guan Wei, Zhou Lei, Li Yan, Yang Erna, Liu Yangyang, Lv Na, Fu Lin, Ding Yi, Wang Nan, Fang Nan, Liu Qian, Wang Binan, Li Fuwei, Zhang Juan, Wang Maoquan, Wang Lili, Jing Yu, Li Yonghui, Yu |
| Clinical significance of FLT3-ITD/CEBPA mutations and minimal residual disease in cytogenetically normal acute myeloid leukemia after hematopoietic stem cell transplantation. Journal of cancer research and clinical oncology 2021 2 147 (9): 2659-2670. Wang Hong, Li Xue-Qian, Chu Tian-Tian, Han Shi-Yu, Qi Jia-Qian, Tang Ya-Qiong, Qiu Hui-Ying, Fu Cheng-Cheng, Tang Xiao-Wen, Ruan Chang-Geng, Wu De-Pei, Han Y |
| Genetic Alteration Profiling of Chinese Lung Adenocarcinoma and Its Effect on Targeted Therapy Efficacy. Frontiers in oncology 2021 12 11 726547. Liu Jie, Xu Wang-Yang, Ye Maosong, Liu Zilong, Li Ch |
Genome-wide association study identifies novel susceptibility loci for KIT D816V positive mastocytosis.
American journal of human genetics 2021 Jan . Galatà Gabriella, García-Montero Andrés C, Kristensen Thomas, Dawoud Ahmed A Z, Muñoz-González Javier I, Meggendorfer Manja, Guglielmelli Paola, Hoade Yvette, Alvarez-Twose Ivan, Gieger Christian, Strauch Konstantin, Ferrucci Luigi, Tanaka Toshiko, Bandinelli Stefania, Schnurr Theresia M, Haferlach Torsten, Broesby-Olsen Sigurd, Vestergaard Hanne, Møller Michael Boe, Bindslev-Jensen Carsten, Vannucchi Alessandro M, Orfao Alberto, Radia Deepti, Reiter Andreas, Chase Andrew J, Cross Nicholas C P, Tapper William |
| The genetic landscape of germline DDX41 variants predisposing to myeloid neoplasms. Blood 2022 6 140 (7): 716-755. Li Peng, Brown Sara, Williams Margaret, White Thomas, Xie Wei, Cui Wei, Peker Deniz, Lei Li, Kunder Christian A, Wang Huan-You, Murray Sarah S, Vagher Jennie, Kovacsovics Tibor, Patel Jay |
| Postoperative hyperprogression disease of pancreatic ductal adenocarcinoma after curative resection: a retrospective cohort study. BMC cancer 2022 Jun 22 (1): 649. Zou Siyi, Wang Xinjing, Chen Haoda, Lin Jiewei, Wen Chenlei, Zhan Qian, Chen Hao, Lu Xiongxiong, Deng Xiaxing, Shen Baiyo |
| Upregulation of FHL1, SPNS3, and MPZL2 predicts poor prognosis in pediatric acute myeloid leukemia patients with FLT3-ITD mutation. Leukemia & lymphoma 2022 3 63 (8): 1897-1906. Eshibona Nasr, Giwa Abdulazeez, Rossouw Sophia Catherine, Gamieldien Junaid, Christoffels Alan, Bendou Hoci |
| Detection of TET2 Mutation in Patients with De Novo Acute Myeloid Leukemia: A Mutation Analysis of 51 Iranian Patients. Asian Pacific journal of cancer prevention : APJCP 2022 3 23 (3): 803-806. Chehreghani Zahra, Sadeghian Mohammad Hadi, Ayatollahi Hossein, Bagheri Parisa, Zafari Zahra, Rezazadeh Omid, Arbab Jafari Pour |
| Differential Implications of CSF3R Mutations in t(8;21) and CEBPA Double Mutated Acute Myeloid Leukemia. Clinical lymphoma, myeloma & leukemia 2022 1 22 (6): 393-404. Wang Biao, Wen Lijun, Wang Zheng, Chen Suning, Qiu Huiyi |
| AML with CEBPA mutations: A comparison of ICC and WHO-HAEM5 criteria in patients with 20% or more blasts. Leukemia research 2023 9 134 107376. Davidson Zhao, Qianghua Zhou, Mojgan Zarif, Entsar Eladl, Cuihong Wei, Eshetu G Atenafu, Andre Schuh, Anne Tierens, Yu Wing Tony Yeung, Mark D Minden, Hong Cha |
| Cytogenetically Normal Acute Myeloid Leukaemia at a Single Centre in South Africa. Hematology/oncology and stem cell therapy 2023 6 16 (4): 397-406. Nicholas Jenkins, Lee-Ann Blanshard, Marian Stone, Estelle Verburgh, Jenna Oosthuizen, Karen Shir |
| [Impact of CSF3R Mutation on Treatment Response and Survival of Patients with Acute Myeloid Leukemia]. Zhongguo shi yan xue ye xue za zhi 2023 6 31 (3): 628-632. Ruo-Qi Li, Xiao-Ling Wen, Xia-Lin Zhang, Chun-Xia Dong, Mei-Fang Wang, Xia-Xia Liu, Yan-Jun Huang, Yan-Hong Tan, Jian-Mei Chang, Rui-Juan Zha |
| UBTF tandem duplications are rare but recurrent alterations in adult AML and associated with younger age, myelodysplasia, and inferior outcome. Blood cancer journal 2023 5 13 (1): 88. Julia-Annabell Georgi, Sebastian Stasik, Jan-Niklas Eckardt, Sven Zukunft, Marita Hartwig, Christoph Röllig, Jan Moritz Middeke, Uta Oelschlägel, Utz Krug, Tim Sauer, Sebastian Scholl, Andreas Hochhaus, Tim H Brümmendorf, Ralph Naumann, Björn Steffen, Hermann Einsele, Markus Schaich, Andreas Burchert, Andreas Neubauer, Kerstin Schäfer-Eckart, Christoph Schliemann, Stefan W Krause, Mathias Hänel, Richard Noppeney, Ulrich Kaiser, Claudia D Baldus, Martin Kaufmann, Carsten Müller-Tidow, Uwe Platzbecker, Wolfgang E Berdel, Hubert Serve, Gerhard Ehninger, Martin Bornhäuser, Johannes Schetelig, Frank Kroschinsky, Christian Thiede, |
| LSC17 score complements genetics and measurable residual disease in acute myeloid leukemia: an ALFA study. Blood advances 2023 5 . Loic Vasseur, Laurène Fenwarth, Jérôme Lambert, Stéphane de Botton, Martin Figeac, Céline Villenet, Maël Heiblig, Pierre-Yves Dumas, Christian Récher, Celine Berthon, Emilie Lemasle, Delphine Lebon, Juliette Lambert, Christine Terré, Karine Celli-Lebras, Hervé Dombret, Claude Preudhomme, Meyling H Cheok, Raphaël A Itzykson, Nicolas Duploy |
| Outcome prediction by the 2022 European LeukemiaNet genetic-risk classification for adults with acute myeloid leukemia: an Alliance study. Leukemia 2023 2 . Mrózek Krzysztof, Kohlschmidt Jessica, Blachly James S, Nicolet Deedra, Carroll Andrew J, Archer Kellie J, Mims Alice S, Larkin Karilyn T, Orwick Shelley, Oakes Christopher C, Kolitz Jonathan E, Powell Bayard L, Blum William G, Marcucci Guido, Baer Maria R, Uy Geoffrey L, Stock Wendy, Byrd John C, Eisfeld Ann-Kathr |
| Analysis of clinical and genomic profiles of therapy-related myeloid neoplasm in Korea. Human genomics 2023 2 17 (1): 13. Yun Jiwon, Song Hyojin, Kim Sung-Min, Kim Soonok, Kwon Seok Ryun, Lee Young Eun, Jeong Dajeong, Park Jae Hyeon, Kwon Sunghoon, Yun Hongseok, Lee Dong So |
| DNA Copy Number Alterations and Copy Neutral Loss of Heterozygosity in Adult Ph-Negative Acute B-Lymphoblastic Leukemia: Focus on the Genes Involved. International journal of molecular sciences 2023 12 24 (24): . Natalya Risinskaya, Maria Gladysheva, Abdulpatakh Abdulpatakhov, Yulia Chabaeva, Valeriya Surimova, Olga Aleshina, Anna Yushkova, Olga Dubova, Nikolay Kapranov, Irina Galtseva, Sergey Kulikov, Tatiana Obukhova, Andrey Sudarikov, Elena Parovichniko |
| Influence on therapeutic outcome of platelet count at diagnosis in patients with de novo non-APL acute myeloid leukemia. BMC cancer 2023 10 23 (1): 1030. Yujiao Zhang, Quan Wu, Baoyi Yuan, Yun Huang, Ling Jiang, Fang Liu, Ping Yan, Yongshuai Jiang, Jieyu Ye, Xuejie Jia |
| The trace that is valuable: serum copper and copper to zinc ratio for survival prediction in younger patients with newly diagnosed acute myeloid leukaemia. BMC cancer 2023 1 23 (1): 14. Li Taotao, Shi Liming, Wei Wei, Xu Jiancheng, Liu Qiu |
| [Restratifying the prognosis of acute myeloid leukemia patients with CEBPA double mutations based on CSF3R mutations and measurable residual disease]. Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi 2023 1 43 (12): 1021-1027. Su L, Tan Y H, Lin H, Han W, Yang Y P, Liu X L, Sun J N, Liu Q J, Gao S |
| Molecular Landscape and Validation of New Genomic Classification in 2668 Adult AML Patients: Real Life Data from the PETHEMA Registry. Cancers 2023 1 15 (2): . Sargas Claudia, Ayala Rosa, Larráyoz María José, Chillón María Carmen, Carrillo-Cruz Estrella, Bilbao-Sieyro Cristina, Prados de la Torre Esther, Martínez-Cuadrón David, Rodríguez-Veiga Rebeca, Boluda Blanca, Gil Cristina, Bernal Teresa, Bergua Juan Miguel, Algarra Lorenzo, Tormo Mar, Martínez-Sánchez Pilar, Soria Elena, Serrano Josefina, Alonso-Domínguez Juan Manuel, García-Boyero Raimundo, Amigo María Luz, Herrera-Puente Pilar, Sayas María José, Lavilla-Rubira Esperanza, Martínez-López Joaquín, Calasanz María José, García-Sanz Ramón, Pérez-Simón José Antonio, Gómez-Casares María Teresa, Sánchez-García Joaquín, Barragán Eva, Montesinos Pau, On Behalf Of Pethema Grou |
| Identification of 16 novel Alzheimer's disease susceptibility loci using multi-ancestry meta-analyses of clinical Alzheimer's disease and AD-by-proxy cases from four whole genome sequencing datasets. medRxiv : the preprint server for health sciences 2024 9 . Julian Daniel Sunday Willett, Mohammad Waqas, Younjung Choi, Tiffany Ngai, Kristina Mullin, Rudolph E Tanzi, Dmitry Prokopen |
| The clinical implications of BCOR mutations in a large cohort of acute myeloid leukemia patients: a 5-year single-center retrospective study. Leukemia & lymphoma 2024 8 1-10. Deyuan Hu, Kai Shen, YuSha Guo, Xie Bing Bao, Ningzheng Dong, Suning Ch |
| Dysregulated immune and metabolic pathways are associated with poor survival in adult acute myeloid leukemia with CEBPA bZIP in-frame mutations. Blood cancer journal 2024 1 14 (1): 15. Feng-Ming Tien, Chi-Yuan Yao, Xavier Cheng-Hong Tsai, Min-Yen Lo, Chien-Yuan Chen, Wan-Hsuan Lee, Chien-Chin Lin, Yuan-Yeh Kuo, Yen-Ling Peng, Mei-Hsuan Tseng, Yu-Sin Wu, Ming-Chih Liu, Liang-In Lin, Ming-Kai Chuang, Bor-Sheng Ko, Ming Yao, Jih-Luh Tang, Wen-Chien Chou, Hsin-An Hou, Hwei-Fang Ti |
| Lung adenocarcinomas with isolated TP53 mutation: A comprehensive clinical, cytopathologic and molecular characterization. Cancer medicine 2024 1 . Rachelle P Mendoza, Heather I-Hsuan Chen-Yost, Pankhuri Wanjari, Peng Wang, Emily Symes, Daniel N Johnson, Ward Reeves, Jeffrey Mueller, Tatjana Antic, Anna Biernac |
- Page last reviewed:Feb 1, 2024
- Content source: